//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Loading...
Laboratory of Dr. Nina Bhardwaj🔬 @TischCancer @SinaiImmunol Immunology & Immunotherapy Posts by Lab Members
Huge congratulations to @michelletran9.bsky.social on graduating!🎓 The Bhardwaj lab team loved celebrating your incredible hard work and achievements over dinner. We are so proud of you and can't wait to see what you do next!✨ Cheers to the next chapter!🥂 #LabFamily #Graduation
@gmestrallet.bsky.social
Trading pipettes for axes! Lab bonding last week was a 10/10 vibe. Looking at the lineup, who do you think lowkey had the best aim?🎯
New paper from the lab! www.cell.com/cell-reports... @gmestrallet.bsky.social @sinaiimmuno.bsky.social
Check out our latest review👏! We dive deep into how cDC1s orchestrate anti-tumor immunity through cross-presentation, immune networking, and spatial organization.
Huge congratulations to Michelle on officially finishing her MD-PhD. It’s been an incredible journey watching her balance the bench and the clinic with such dedication. We couldn’t be prouder of everything she’s accomplished. Cheers to Dr. Michelle!🥂 ##MDPhD #Graduation
www.mountsinai.org/about/newsro...
Oncologists and researchers at the ASCO 2026 conference give a standing ovation after the experimental drug daraxonrasib nearly doubles survival in a metastatic pancreatic cancer trial! #AGoodPlace Source: www.reddit.com/r/Damnthatsi...
6d
1mo
1mo
1mo
22h
1mo
1mo
Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models - @mitkochinstitute.bsky.social go.nature.com/42td2fh
10d
Video
29d
Mestrallet et al. focused on resistance mechanisms that limit anti-PD-1 efficacy in colorectal cancer (50% to 100% failure depending on mismatch repair status). bit.ly/49qWVm8 @sinaiimmuno.bsky.social @gmestrallet.bsky.social @bhardwajlab.bsky.social
23d
Michelle says: Be kind. Always. ❤️
Nature Biotechnology
Ward, Kar, Balan, and Bhardwaj @bhardwajlab.bsky.social review how conventional type 1 #DendriticCells (cDC1s) coordinate antitumor immunity through cross-presentation, immune cell networking, and spatial organization in tumors. rupress.org/jem/article/... #CancerFocus #Immunotherapy
ACIR
22h
Journal of Experimental Medicine
Immune-remodeling mRNAs delivered in lipid nanoparticles boost antitumor immunity.
go.nature.com
Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models - Nature Biotechnology